B-intervention	0	11	Indocyanine
I-intervention	12	17	green
I-intervention	18	30	fluorescence
I-intervention	30	31	-
I-intervention	31	37	guided
I-intervention	38	48	lumpectomy
O	49	51	of
O	52	63	nonpalpable
O	64	70	breast
O	71	77	cancer
O	78	84	versus
B-control	85	89	wire
I-control	89	90	-
I-control	90	96	guided
I-control	97	105	excision
O	105	106	:
O	107	108	A
O	109	119	randomized
O	120	128	clinical
O	129	134	trial
O	134	135	.

O	136	139	The
O	140	143	use
O	144	146	of
O	147	151	wire
O	152	164	localization
O	165	166	(
O	166	168	WL
O	168	169	)
O	170	173	for
O	174	183	excisions
O	184	186	of
O	187	198	nonpalpable
O	199	205	breast
O	206	212	cancer
O	213	214	(
O	214	217	NBC
O	217	218	)
O	219	222	has
O	223	230	several
O	231	244	disadvantages
O	244	245	.

O	246	249	The
O	250	257	purpose
O	258	260	of
O	261	265	this
O	266	271	study
O	272	275	was
O	276	278	to
O	279	287	evaluate
O	288	291	the
O	292	295	use
O	296	298	of
O	299	310	indocyanine
O	311	316	green
O	316	317	-
O	317	323	guided
O	324	335	nonpalpable
O	336	342	breast
O	343	349	cancer
O	350	356	lesion
O	357	369	localization
O	370	371	(
O	371	376	INBCL
O	376	377	)
O	378	381	and
O	382	384	to
O	385	392	compare
O	393	395	it
O	396	400	with
O	401	403	WL
O	403	404	.

O	405	406	A
O	407	412	total
O	413	415	of
B-total-participants	416	418	62
B-eligibility	419	427	patients
I-eligibility	428	432	with
I-eligibility	433	434	a
I-eligibility	435	447	preoperative
I-eligibility	448	460	histological
I-eligibility	461	470	diagnosis
I-eligibility	471	473	of
I-eligibility	474	477	NBC
I-eligibility	478	485	lesions
I-eligibility	486	490	that
I-eligibility	491	496	could
I-eligibility	497	499	be
I-eligibility	500	510	visualized
I-eligibility	511	515	with
I-eligibility	516	526	ultrasound
I-eligibility	527	530	and
I-eligibility	531	542	mammography
O	543	547	were
O	548	558	randomized
O	559	561	to
O	562	567	INBCL
O	568	570	or
O	571	573	WL
O	573	574	.

O	575	583	Patients
O	584	588	with
O	589	603	preoperatively
O	604	613	diagnosed
O	614	621	primary
O	622	628	ductal
O	629	638	carcinoma
O	639	641	in
O	642	646	situ
O	647	650	and
O	651	661	multifocal
O	662	669	disease
O	670	674	were
O	675	683	excluded
O	684	688	from
O	689	692	the
O	693	698	study
O	698	699	.

O	700	712	Significance
O	713	716	was
O	717	727	considered
O	728	730	at
O	731	732	P
O	733	734	<
O	735	736	0
O	736	737	.
O	737	739	05
O	739	740	.

O	741	743	Of
O	744	747	all
B-total-participants	748	750	62
O	751	759	excision
O	759	760	,
B-intervention-participants	761	763	32
O	764	765	(
O	765	767	51
O	767	768	.
O	768	769	6
O	769	770	%
O	770	771	)
O	772	776	were
O	777	783	guided
O	784	786	by
O	787	792	INBCL
O	793	796	and
B-control-participants	797	799	30
O	800	801	(
O	801	803	48
O	803	804	.
O	804	805	4
O	805	806	%
O	806	807	)
O	808	810	by
O	811	813	WL
O	813	814	.

O	815	819	Both
O	820	830	techniques
O	831	839	resulted
O	840	842	in
B-iv-bin-percent	843	846	100
I-iv-bin-percent	846	847	%
B-outcome	848	857	retrieval
I-outcome	858	860	of
I-outcome	861	864	the
I-outcome	865	872	lesions
O	872	873	.

O	874	877	The
B-outcome	878	882	rate
I-outcome	883	885	of
I-outcome	886	891	clear
I-outcome	892	899	margins
O	900	903	was
O	904	917	significantly
O	918	924	higher
O	925	927	in
O	928	931	the
O	932	937	INBCL
O	938	943	group
O	944	945	(
B-iv-bin-percent	945	947	87
I-iv-bin-percent	947	948	.
I-iv-bin-percent	948	949	5
I-iv-bin-percent	949	950	%
O	950	951	;
B-iv-bin-abs	952	954	28
O	954	955	/
B-intervention-participants	955	957	32
O	957	958	)
O	959	967	compared
O	968	970	to
O	971	974	the
O	975	977	WL
O	978	979	(
B-cv-bin-percent	979	981	63
I-cv-bin-percent	981	982	.
I-cv-bin-percent	982	983	3
I-cv-bin-percent	983	984	%
O	984	985	,
B-cv-bin-abs	986	988	19
O	988	989	/
B-control-participants	989	991	30
O	991	992	)
O	993	994	(
O	994	995	P
O	996	997	=
O	998	999	0
O	999	1000	.
O	1000	1003	026
O	1003	1004	)
O	1004	1005	,
O	1006	1014	reducing
O	1015	1018	the
O	1019	1030	requirement
O	1031	1033	of
O	1034	1036	re
O	1036	1037	-
O	1037	1045	excision
O	1045	1046	.

O	1047	1051	When
O	1052	1059	results
O	1060	1062	of
O	1063	1066	the
O	1067	1074	excised
O	1075	1081	tissue
O	1082	1085	are
O	1086	1091	taken
O	1092	1096	into
O	1097	1104	account
O	1104	1105	,
O	1106	1109	the
B-outcome	1110	1114	mean
I-outcome	1115	1121	volume
I-outcome	1122	1124	of
I-outcome	1125	1128	the
I-outcome	1129	1134	INBCL
I-outcome	1135	1143	specimen
O	1144	1147	was
O	1148	1150	56
O	1151	1154	cm3
O	1155	1159	less
O	1160	1164	than
O	1165	1169	that
O	1170	1172	of
O	1173	1176	the
O	1177	1179	WL
O	1180	1185	group
O	1185	1186	,
O	1187	1195	although
O	1196	1200	this
O	1201	1204	was
O	1205	1208	not
O	1209	1222	significantly
O	1223	1232	different
O	1233	1234	(
O	1234	1235	P
O	1236	1237	=
O	1238	1239	0
O	1239	1240	.
O	1240	1243	058
O	1243	1244	)
O	1244	1245	.

O	1246	1251	INBCL
O	1252	1255	for
O	1256	1260	NBCs
O	1261	1264	was
O	1265	1269	more
O	1270	1278	accurate
O	1279	1283	than
O	1284	1286	WL
O	1286	1287	,
O	1288	1295	because
O	1296	1298	it
O	1299	1308	optimized
O	1309	1312	the
O	1313	1320	surgeon
O	1320	1321	'
O	1321	1322	s
O	1323	1330	ability
O	1331	1333	to
O	1334	1340	obtain
O	1341	1346	clear
O	1347	1354	margins
O	1354	1355	.

O	1356	1357	A
O	1358	1365	smaller
O	1366	1372	volume
O	1373	1375	of
O	1376	1379	the
O	1380	1386	tissue
O	1387	1390	may
O	1391	1393	be
O	1394	1401	excised
O	1402	1404	by
O	1405	1410	using
O	1411	1416	INBCL
O	1417	1426	technique
O	1426	1427	.

O	1428	1437	Therefore
O	1438	1443	INBCL
O	1444	1446	is
O	1447	1449	an
O	1450	1460	attractive
O	1461	1472	alternative
O	1473	1475	to
O	1476	1478	WL
O	1478	1479	.
